Maintenance of cellular respiration indicates drug resistance in acute myeloid leukemia
Katharina Henkenius, Elisabeth Mack(Universitätsklinikum Gießen und Marburg), Miriam Rehberger(Philipps University of Marburg), Cornelia Brendel(Philipps University of Marburg), Andreas Neubauer(RWTH Aachen University), Raimo Hartmann(Philipps University of Marburg), Christina Barckhausen(Philipps University of Marburg), Melanie Märken(Philipps University of Marburg), Wolfgang J. Parak(Universität Hamburg), Tom Kaiser(Philipps University of Marburg), Brandon Greene(Philipps University of Marburg), Stephan Metzelder(Philipps University of Marburg)
Cited by 42
Related Papers
Diverse Applications of Nanomedicine
|ACS Nano|2017|1.4k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
Prospects of Nanoscience with Nanocrystals
|ACS Nano|2015|1.2k
A Decade of the Protein Corona
|ACS Nano|2017|651
Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)
|Journal of Clinical Oncology|2005|573